남성 인유두종 바이러스 감염의 치료

키워드

참고문헌 (61)

1. Munoz N, "Epidemiologic classification of human papillomavirus types associated with cervical cancer", N Engl J Med, 348, pp.518~527 (2003)
2. Schiffman M, "Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing", Cancer, 111, pp.145~153 (2007)
3. "Vaccines against human papillomavirus" (2010)[URL]
4. "Genital HPV infection—STD fact sheet" (2010)[URL]
5. Dunne EF, "Prevalence of HPV infection among females in the United States", JAMA, 297, pp.813~819 (2007)
6. Pham TH, "Human papillomavirus infection among women in South and North Vietnam", Int J Cancer, 104, pp.213~220 (2003)
7. Bosch FX, "Prevalence of human papillomavirus in cervical cancer:a worldwide perspective", J Natl Cancer Inst, 87, pp.796~802 (1995)
8. Stanley M, "Immune responses to human papillomavirus", Vaccine, 24(Suppl 1), pp.S16~S22 (2006)
9. de Villiers EM, "Classification of papillomaviruses", Virology, 324, pp.17~27 (2004)
10. Derkay CS, "Recurrent respiratory papillomatosis: a review", Laryngoscope, 118, pp.1236~1247 (2008)
11. Clifford G, "Chapter 3:HPV type-distribution in women with and without cervical neoplastic diseases", Vaccine, 24(Suppl 3), pp.S3 (2006), 26~S3[DOI]
12. Mantovani F, "The human papillomavirus E6 protein and its contribution to malignant progression", Oncogene, 20, pp.7874~7887 (2001)
13. Münger K, "Biological activities and molecular targets of the human papillomavirus E7 oncoprotein", Oncogene, 20, pp.7888~7898 (2001)
14. Castle PE, "Beyond human papillomavirus: the cervix, exogenous secondary factors, and the development of cervical precancer and cancer", J Low Genit Tract Dis, 8, pp.224~230 (2004)
15. Burchell AN, "Chapter 6:epidemiology and transmission dynamics of genital HPV infection", Vaccine, 24(Suppl 3), pp.S3 (2006), 52~S3[DOI]
16. Doorbar J, "The papillomavirus life cycle", J Clin Virol, 32(Suppl 1), pp.S7~S15 (2005)
17. Koutsky LA, "A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection", N Engl J Med, 327, pp.1272~1278 (1992)
18. Myers ER, "Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis", Am J Epidemiol, 151, pp.1158~1171 (2000)
19. Ostor AG, "Natural history of cervical intraepithelial neoplasia:a critical review", Int J Gynecol Pathol, 1993, pp.186~192 (1993)
20. Pinto AP, "Natural history of cervical neoplasia : defining progression and its consequence", Clin Obstet Gynecol, 43, pp.352~362 (2000)
21. Richart RM, "A follow-up study of patients with cervical dysplasia", Am J Obstet Gynecol, 105, pp.386~393 (1969)
22. Parkin DM, "Chapter 2: the burden of HPV-related cancers", Vaccine, 24(Suppl 3), pp.S3 (2006), 11~S3[DOI]
23. Koutsky LA, "Epidemiology of genital human papillomavirus infection", Epidemiol Rev, 10, pp.122~163 (1988)
24. Burk RD, "Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors", Sex Transm Dis, 23, pp.333~341 (1996)
25. Ho GY, "Natural history of cervicovaginal papillomavirus infection in young women", N Engl J Med, 338, pp.423~428 (1998)
26. Joo WD, "Prevalence of human papillomavirus infection in Korean women : risks of abnormal pap smear and cervical neoplasia", Korean J Gynecol Oncol Colposc, 15, pp.309~316 (2004)
27. 김성희, "일부 여성에서 인유두종 바이러스 감염률과 관련요인", Korean Journal of Family Medicine, 30(12), pp.972~978 (2009), 대한가정의학회
28. 이은희, "Prevalence and Distribution of Human Papillomavirus Infection in Korean Women as Determined by Restriction Fragment Mass Polymorphism Assay", Journal of Korean Medical Science, 27(9), pp.1091~1097 (2012), 대한의학회
29. Clifford GM, "Serologic response to oncogenic human papillomavirus types in male and female university students in Busan, South Korea", Cancer Epidemiol Biomarkers Prev, 16, pp.1874~1879 (2007)
30. Choi BS, "Genital human papillomavirus genotyping by HPV oligonucleotide microarray in Korean commercial sex workers", J Med Virol, 71, pp.440~445 (2003)
31. Cook LS, "Clinical presentation of genital warts among circumcised and uncircumcised heterosexual men attending an urban STD clinic", Genitourin Med, 69, pp.262~264 (1993)
32. Sonnex C, "Anal human papillomavirus infection in heterosexuals with genital warts: prevalence and relation with sexual behaviour", BMJ, 303, pp.1243~ (1991)
33. Beutner KR, "External genital warts: report of the American Medical Association Consensus Conference. AMA Expert Panel on External Genital Warts", Clin Infect Dis, 27, pp.796~806 (1998)
34. Beutner KR, "Genital warts and their treatment", Clin Infect Dis, 28(ppl 1), pp.S37~S56 (1999)
35. Balik E, "A surgical approach to anogenital Buschke Loewenstein tumours (giant condyloma acuminata)", Acta Chir Belg, 109, pp.612~616 (2009)
36. Wessendorf U, "Giant condyloma of the penis with malignant transformation associated with lichen sclerosus et atrophicus", Hautarzt, 60, pp.787~789 (2009)
37. Ihm CW, "Bowenoid epidermotropic metastatic squamous cell carcinoma", J Cutan Pathol, 23, pp.479~484 (1996)
38. Collina G, "Detection of human papillomavirus in extragenital Bowen's disease using in situ hybridization and polymerase chain reaction", Am J Dermatopathol, 17, pp.236~241 (1995)
39. Ikenberg H, "Human papillomavirus type-16-related DNA in genital Bowen's disease and in Bowenoid", Int J Cancer, 32, pp.563~565 (1983)
40. Wade TR, "Bowenoid papulosis of the genitalia", Arch Dermatol, 115, pp.306~308 (1979)
41. Lloyd KM, "Multicentric pigmented Bowen's disease of the groin", Arch Dermatol, 101, pp.48~51 (1970)
42. Wade TR, "Bowenoid papulosis of the penis", Cancer, 42, pp.1890~1903 (1978)
43. Pala S, "The presence of HPV types 6", 11, 16, 33, pp.51 in Bowenoid papulosis demonstrated by DNA in situ hybridization, Int J STD AIDS[DOI]
44. Yoneta A, "Development of squamous cell carcinoma by two high-risk human papillomaviruses (HPVs), a novel HPV-67 and HPV-31from bowenoid papulosis", Br J Dermatol, 143, pp.604~608 (2000)
45. Hording U, "Human papillomaviruses and multifocal genital neoplasia", Int J Gynecol Pathol, 15, pp.230~234 (1996)
46. Wolf R, "Treatment of genital warts: facts and controversies", Clin Dermatol, 28, pp.546~548 (2010)
47. Stone KM, "Treatment of external genital warts : a randomised clinical trial comparing podophyllin, cryotherapy, and electrodesiccation", Genitourin Med, 66, pp.16~19 (1990)
48. Abdullah AN, "Treatment of external genital warts comparing cryotherapy(liquid nitrogen)and trichloroacetic acid", Sex Transm Dis, 20, pp.344~345 (1993)
49. Roongpisuthipong A, "Current therapy for condyloma acuminata of the patients attending female STD Unit, Siriraj Hospital", J Med Assoc Thai, 93, pp.643~646 (2010)
50. Perry CM, "Topical imiquimod : a review of its use in genital warts", Drugs, 58, pp.375~390 (1999)
51. Edwards L, "Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus", Arch Dermatol, 134, pp.25~30 (1998)
52. Forcier M, "An overview of human papillomavirus infection for the dermatologist: disease, diagnosis, management, and prevention", Dermatol Ther, 23, pp.458~476 (2010)
53. Miller RL, "Imiquimod applied topically : a novel immune response modifier and new class of drug", Int J Immunopharmacol, 21, pp.1~14 (1999)
54. Keating MA, "Condyloma acuminatum of the bladder and ureter: case report and review of the literature", J Urol, 133, pp.465~467 (1985)
55. Dretler SP, "The eradication of intraurethral condyloma acuminata with 5 per cent 5-fluorouracil cream", J Urol, 113, pp.195~198 (1975)
56. Wein AJ, "Treatment of urethral condyloma acuminatum with 5-fluorouracil cream", Urology, 9, pp.413~415 (1977)
57. Blokker RS, "Comparing thulium laser and Nd : YAG laser in the treatment of genital and urethral condylomata acuminata in male patients", Lasers Surg Med, 45, pp.582~588 (2013)
58. Lee KC, "Genital and urethral warts", Korean J Urogenit Tract Infect Inflamm, 5, pp.151~160 (2010)
59. Manhart LE, "Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia?", Sex Transm Dis, 29, pp.725~735 (2002)
60. Hagensee ME, "Self-assembly of human papillomavirus type 1 capsids by expression of the L1protein alone or by coexpression of the L1 and L2 capsid proteins", J Virol, 67, pp.315~322 (1993)
61. Mao C, "Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia: a randomized controlled trial", Obstet Gynecol, 107, pp.18~27 (2006)

관련 논문AI추천